HELION BIOTECH ApS: Financial statements 2019
CVR: 31758106
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
HELION BIOTECH ApS (CVR 31758106) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -18,093 and a net result of DKK -22,792 compared with DKK 3,945,456 the year before. Equity in the 2019 report amounted to DKK 180,643. The solvency ratio was 31.4%.
- Gross Profit
- DKK -18,093
- Profit/Loss
- DKK -22,792
- Equity
- DKK 180,643
- Total Assets
- DKK 575,797
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -18 t. | -23 t. | 181 t. | - |
| 2018 | - | 5 mio. | 3.9 mio. | 563 t. | - |
| 2017 | - | -12 t. | -14 t. | 218 t. | - |
| 2016 | - | -82 t. | -84 t. | 932 t. | - |
| 2015 | - | -105 t. | -105 t. | 2.1 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
HELION BIOTECH ApS has published its annual report for 2018. Gross profit came to DKK 5,004,481, and the net result was DKK 3,945,456.
About HELION BIOTECH ApS
HELION BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Steffen Thiel (chair), Jens Christian Jensenius and Per Bo Pedersen Fischer. The company is owned by HELION HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -27,115 and a net result of DKK -32,019 compared with DKK -43,895 the year before. Equity in the 2025 report amounted to DKK 117,514.